0 Yorumlar
0 hisse senetleri
233 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Cancer Treatment Drugs Market to Reach USD 359.83 Billion by 2032 Driven by Immunotherapy and Precision Oncology AdvancementsAccording to a report by Intel Market Research, the global cancer treatment drugs market was valued at USD 193.12 billion in 2024 and is projected to grow from USD 211.45 billion in 2025 to USD 359.83 billion by 2032, exhibiting a CAGR of 9.5% during the forecast period. The market is witnessing strong growth due to the rising global burden of cancer, increasing adoption of targeted therapies...0 Yorumlar 0 hisse senetleri 109 Views 0 önizleme
-
Global endometrial cancer treatment market growth outlook with 4.5% CAGR (2025–2031)According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...0 Yorumlar 0 hisse senetleri 242 Views 0 önizleme
-
Global endometrial cancer treatment market growth outlook with 4.5% CAGR (2025–2031)According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...0 Yorumlar 0 hisse senetleri 267 Views 0 önizleme
-
Global Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme1
-
Global Endometrial Cancer Treatment Market Insights & Growth Trends | CAGR 4.5% (2025–2031)According to a newly published market research report by 24LifeSciences, global endometrial cancer treatment market was valued at USD 21,380 million in 2024 and is projected to reach USD 28,790 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 2025–2031. Endometrial cancer, classified under gynecologic malignancies, originates in the...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme1
-
Global Prostate Cancer Treatment Drugs Market: Projected to Reach USD 18.74 Billion by 2031According to a newly published market research report by 24LifeSciences, global prostate cancer treatment drugs market was valued at USD 14.03 billion in 2024 and is projected to reach USD 18.74 billion by 2031, growing at a compound annual growth rate (CAGR) of 4.3% during the forecast period 2025-2031. Prostate cancer treatment drugs represent a critical segment in oncology...0 Yorumlar 0 hisse senetleri 92 Views 0 önizleme
-
Global Prostate Cancer Treatment Drugs Market: Projected to Reach USD 18.74 Billion by 2031According to a newly published market research report by 24LifeSciences, global prostate cancer treatment drugs market was valued at USD 14.03 billion in 2024 and is projected to reach USD 18.74 billion by 2031, growing at a compound annual growth rate (CAGR) of 4.3% during the forecast period 2025-2031. Prostate cancer treatment drugs represent a critical segment in oncology...0 Yorumlar 0 hisse senetleri 117 Views 0 önizleme
-
Global Prostate Cancer Treatment Drugs Market: Projected to Reach USD 18.74 Billion by 2031According to a newly published market research report by 24LifeSciences, global prostate cancer treatment drugs market was valued at USD 14.03 billion in 2024 and is projected to reach USD 18.74 billion by 2031, growing at a compound annual growth rate (CAGR) of 4.3% during the forecast period 2025-2031. Prostate cancer treatment drugs represent a critical segment in oncology...0 Yorumlar 0 hisse senetleri 132 Views 0 önizleme
-
Global Thymus Cancer Market Growth and Treatment Innovations 2031According to a newly published market research report by 24LifeSciences, theglobal thymus cancer market was valued at USD 149 million in 2025 and is projected to reach USD 213 million by 2031, growing at a compound annual growth rate (CAGR) of 5.3% during the forecast period 2025–2031. Thymus cancer, clinically referred to as thymoma or thymic carcinoma, is a rare malignancy...0 Yorumlar 0 hisse senetleri 211 Views 0 önizleme
-
Global Thymus Cancer Market Growth and Treatment Innovations 2031According to a newly published market research report by 24LifeSciences, theglobal thymus cancer market was valued at USD 149 million in 2025 and is projected to reach USD 213 million by 2031, growing at a compound annual growth rate (CAGR) of 5.3% during the forecast period 2025–2031. Thymus cancer, clinically referred to as thymoma or thymic carcinoma, is a rare malignancy...0 Yorumlar 0 hisse senetleri 197 Views 0 önizleme
-
Gynecological Cancer Drugs Market Demand Analysis: Growing Need for Effective and Targeted Cancer Treatment SolutionsThe global Gynecological Cancer Drugs Market is witnessing significant expansion due to the increasing prevalence of gynecological cancers, growing awareness regarding early diagnosis, and continuous advancements in oncology therapeutics. According to market analysis, the Gynecological Cancer Drugs Market size is expected to reach US$ 28.38 billion by 2034 from US$ 15.62 billion...0 Yorumlar 0 hisse senetleri 137 Views 0 önizleme
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Yorumlar 0 hisse senetleri 8K Views 0 önizleme
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 Yorumlar 0 hisse senetleri 4K Views 0 önizleme
-
Bladder Cancer Market to Reach USD 4.1 Billion by 2031 | CAGR 6.7%According to a newly published market research report by 24LifeSciences, global bladder cancer market was valued at USD 2.6 billion in 2024 and is projected to reach USD 4.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period 2025-2031. Bladder cancer remains one of the most prevalent urological malignancies worldwide, with non-muscle invasive...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Yorumlar 0 hisse senetleri 4K Views 0 önizleme1
-
Checkpoint Inhibitor Refractory Cancer Market to Reach USD 8.75 Billion by 2032 | CAGR 9.6%According to a newly published market research report by 24LifeSciences, global checkpoint inhibitor refractory cancer market was valued at USD 4.2 billion in 2024 and is projected to reach USD 8.75 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period 2025–2032. Checkpoint inhibitor refractory cancer occurs when tumors develop...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
Chromatography Instrumentation Market Scope and Growth Analysis by 2034The Chromatography instrumentation has become an essential component in modern analytical science, enabling precise separation, identification, and quantification of chemical compounds across multiple industries. Its application spans pharmaceuticals, biotechnology, environmental monitoring, and food safety testing, where accuracy and compliance are critical. The increasing complexity of...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme1
-
Cytokine Market Future Outlook and Investment OpportunitiesThe growing focus on immunology, targeted therapies, and advanced biologics is significantly driving the expansion of the cytokine industry worldwide. Cytokines play a vital role in regulating immune responses, inflammation, and cell signaling, making them essential in the treatment of cancer, autoimmune disorders, infectious diseases, and inflammatory conditions. Increasing investments in...0 Yorumlar 0 hisse senetleri 454 Views 0 önizleme
-
Estramustine Phosphate Sodium Market Dynamics and Opportunities 2031Estramustine Phosphate Sodium is an oncology drug primarily indicated for the treatment of metastatic or advanced prostate cancer. It integrates estrogenic components with cytotoxic activity to inhibit cancer cell proliferation. By targeting tumor cell division pathways, it supports disease control in patients requiring specialized therapeutic interventions. Market Overview The Estramustine...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 Yorumlar 0 hisse senetleri 3K Views 0 önizleme
Arama Sonuçları